Treatment News : HIV Meds Protect Against Doubled Cancer Risk in Positive Men

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » May 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

May 6, 2013

HIV Meds Protect Against Doubled Cancer Risk in Positive Men

HIV causes a nearly twofold increase in risk of non-AIDS-defining cancers (NADCs) among men, but antiretrovirals (ARVs) may negate this elevated threat, Medical Daily reports. Publishing their findings in the journal AIDS Research and Human Retroviruses, Italian researchers conducted a retrospective analysis of 5,090 HIV-positive people receiving care in the Local Health Authority of Brescia.

The investigators identified 138 cancers among 131 participants, for a mean incidence rate of 42.6 per 10,000 person years. The median age of diagnosis was 49, with a range of 28 to 78 years old. Comparing participants’ rates of cancer to similar HIV-negative residents of the region, the investigators found that the men had a 1.86-fold increased rate of NADCs. The study found a 3.59-fold increased risk of lung and a 3.11-fold increased rate of testicular cancer among the participants; the investigators theorized that smoking was a major contributing factor. Factors outside of HIV that raised the risk of NADCs included older age, with a 10 percent increase in risk for each additional year of age, and either a shorter or a lack of exposure to ARVs, which increased the risk 2.31-fold.

The researchers concluded that “the use of [ARVs] appeared to be beneficial in protecting against the development of these malignancies.”

To read the Medical Daily story, click here.

To read the study abstract, click here.

Search: cancer, HIV-positive men, non-AIDS-defining cancers, NADCs, antiretorvirals, ARVs, AIDS Research and Human Retroviruses, Local Health Authority of Brescia, smoking.


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    chrisf
    san jose
    California


    usuallyhappy
    Palm Springs
    California


    pevans
    San Francisco
    California


    kmfdm221
    Arcata
    California
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been tested for hepatitis C?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.